Overview

Using Flavonoids to Kill Hepatitis B Virus

Status:
COMPLETED
Trial end date:
2025-06-20
Target enrollment:
Participant gender:
Summary
The composition treats Acute Hepatitis, Chronic Hepatitis, Cirrhosis, and hepatocellular carcinoma (S.B.Flavonoids) at an early stage. The product is ascorbic acid, L-Arginine hydrochloride, Kaempferol, Urinariaflavone, 5,6-dihydroxy-7,8,4'-trimethoxy-flavone, Quercetin, and Rutin. These components have participated in protecting liver cell membranes, focusing on reducing liver stress and supporting their structure, repairing and regenerating new liver parenchyma, preventing fibrosis cell generation, and preventing liver cancer cell growth at an early stage. The composition supplements precursors that help the body strengthen antibodies and reduce the risk of inflammation, and restore the physiological and biochemical functions of liver cells after chronic inflammation.
Phase:
PHASE4
Details
Lead Sponsor:
Trieu, Nguyen Thi, M.D.
Treatments:
Flavonoids
Tenofovir